08:02 AM EDT, 10/30/2024 (MT Newswires) -- AbbVie ( ABBV ) reported Q3 adjusted earnings Wednesday of $3.00 per diluted share, up from $2.95 a year earlier.

Analysts surveyed by Capital IQ expected $2.92.

Net revenue for the quarter ended Sept. 30 was $14.46 billion, up from $13.93 billion a year earlier. Analysts surveyed by Capital IQ expected $14.28 billion.

The biopharmaceutical company raised its fiscal 2024 adjusted EPS guidance to a range of $10.90 to $10.94, from $10.67 to $10.87 previously. Analysts surveyed by Capital IQ expect $10.85.

Shares of AbbVie ( ABBV ) were up 1.5% in recent Wednesday premarket activity.